Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Niacinamide wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Kojic Acid and Niacinamide have evidence — compare verdict strength side-by-side.
Topical cosmetic only. Kojic acid is typically used at roughly 1-2% in leave-on serums or creams (or as the more stable kojic acid dipalmitate), applied to areas of hyperpigmentation once or twice daily, often alongside other brighteners and daily sunscreen. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
any
Leave-on topical serum or cream (≈1-2% kojic acid, or kojic acid dipalmitate)
Topical cosmetic only. Niacinamide is typically formulated at 2-5% in leave-on serums, creams, or gels and applied to clean skin once or twice daily (AM and/or PM). It layers well under sunscreen and with most other actives. There is no oral, injectable, or systemic dose in this cosmetic context — it is not ingested here. This library does not provide an ingestion protocol.
any
Leave-on topical serum or cream (2-5% niacinamide)
Throughout
8-12 weeks
Throughout
1-12 months
Throughout
4-12 weeks
2-12 weeks
2-8 weeks
Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid.
Dermatol Surg (1999) · Rct · n=40
Split-face randomized design in 40 women with epidermal melasma: 2% kojic acid added to a 10% glycolic acid + 2% hydroquinone base vs the base alone
Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.
J Cosmet Dermatol (2023) · Meta analysis
Pooled 45 efficacy studies (2359 patients) of topical melasma treatments using MASI standardised mean differences
Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study.
Indian J Dermatol (2013) · Rct · n=80
80 melasma patients randomized over 12 weeks to kojic acid 1% alone, kojic acid + hydroquinone 2%, kojic acid + betamethasone, or all three (MASI-assessed)
Niacinamide: A B vitamin that improves aging facial skin appearance.
Dermatol Surg (2005) · Rct · n=50
Double-blind, left-right randomized split-face design: 5% niacinamide vs vehicle applied twice daily for 12 weeks in 50 white women with facial photoaging
The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
Br J Dermatol (2002) · Rct · n=18
Paired clinical trial: 18 subjects with hyperpigmentation used 5% niacinamide vs vehicle moisturizer (plus a separate facial-tanning arm)
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.
Dermatol Res Pract (2011) · Rct · n=27
Split-face RCT in 27 melasma patients: 4% niacinamide vs 4% hydroquinone (HQ) for 8 weeks, both with sunscreen
Niacinamide has a higher evidence score (6/10 vs 6/10) and wins in 1 of 3 categories.
For even skin tone, Niacinamide has a higher relevance score (75 vs 70).
No known interactions between Kojic Acid and Niacinamide have been documented in our database. However, always consult a healthcare provider before combining supplements.